Featured
Breakthrough Targeted Therapies Offer Hope for Myasthenia Gravis Patients
Gene Therapy Oct 21, 2026
Patient Briefs Oct 20, 2026
Tumor Watch Oct 19, 2026
Targeted therapies are offering new hope for myasthenia gravis patients by addressing treatment gaps and...
Tirzepatide and semaglutide have similar asthma risks in adults with type 2 diabetes and asthma.
Experts redefine obesity treatment success metrics to include metabolic health and body composition improvements in...
Read our latest NF Research articles.
FDA to decide on satralizumab for thyroid eye disease treatment by October 15.
Doctors recommend lifestyle changes and new medications for MASH treatment. Learn about this progressive liver...
In a culture obsessed with speed, efficiency, and instant gratification, the way we begin our...
Targeted therapies are offering new hope for myasthenia gravis patients by addressing treatment gaps and improving outcomes.
Targeted therapies are offering new hope for myasthenia gravis patients by addressing treatment gaps and improving outcomes.
Alzheimer's Association aims to improve brain care with new initiative focused on dementia care and treatment.
Medicare kidney screenings rose since 2016, yet many still miss early chronic kidney disease (CKD) diagnoses despite testing increases.
The new stroke rehabilitation guidelines urge clinicians to begin therapy within 48 hours of admission, covering physical, cognitive and mental...
FDA to decide on satralizumab for thyroid eye disease treatment by October 15.
Doctors recommend lifestyle changes and new medications for MASH treatment. Learn about this progressive liver condition and effective management strategies.
In a culture obsessed with speed, efficiency, and instant gratification, the way we begin our mornings often sets the tone...
Strengths, limits, and evolution of the FIB-4 liver fibrosis tool, a noninvasive method for assessing liver health.
Study suggests warfarin may be a viable option for low-risk atrial fibrillation patients when cost concerns limit DOAC use, with...
Tirzepatide and semaglutide have similar asthma risks in adults with type 2 diabetes and asthma.